Health Care/Hospital
LISCure Biosciences Has Completed Seed Funding of USD 5 Million for Bacteria-mediated Immunotherapy R&D Enhancement
SEOUL, South Korea, July 25, 2019 /PRNewswire/ -- LISCure Biosciences, a biotech company that researches and develops bacteria-mediated immunotherapy, has succeeded in attracting5 million USD of seed funding investment. NHN Investment, Shinhan Investment, and KB Securities have participated in th...
2019-07-25 21:00
2229
Volition Announces Exercise of Warrant to Purchase $4.8 Million in Common Stock
AUSTIN, Texas, July 24, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced a further strengthening of its balance sheet with an existing investor exercising the balance of its warrant to purchase$4.8 million in aggregate amount of shares of our common stock...
2019-07-25 04:05
9664
NanoCellect Biomedical Expands Distribution to Australia and New Zealand
Company enters exclusive agreement with Millennium Science Pty Ltd SAN DIEGO, California, July 24, 2019 /PRNewswire/ -- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agreement wit...
2019-07-24 21:57
1772
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group
SHANGHAI, July 24, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Harbin Pharmaceutical Group Holding Co., Ltd. (HPGC, SHSE: 600664), which has...
2019-07-24 20:00
8236
111 Wins Recognition as Pioneer of New Healthtech
"Growth Champion" Award for "1 Drugstore" SHANGHAI, June 23, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that its online retail pharmacy "1 Drugstore" has won two prestigious industry awards. B...
2019-07-23 21:53
7029
Shanghai Concord Medical Cancer Center has Accepted Medical Insurance Settlement from Patients from certain Yangtze River Delta Regions
BEIJING, July 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solutions provider and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced that...
2019-07-23 18:03
9722
Innopresso launches Indiegogo campaign for its touchpad-keyboard Mokibo
SEOUL, South Korea, July 23, 2019 /PRNewswire/ -- Innopresso, a member company of theBorn2Global Centre, successfully launched its smart keyboard "Mokibo" on Indiegogo (https://igg.me/at/mokibo/x#/).   Mokibo is a smart keyboard that combines the functions of a keyboard with t...
2019-07-23 15:30
2365
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...
2019-07-22 12:17
7268
VolitionRx Limited Commences Lung Cancer Clinical Study with Fosun Long March in China
AUSTIN, Texas, July 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") has executed a contract under the previously announced Memorandum of Understanding, with Shanghai Fosun Long March Medical Science Co., Ltd. ("Fosun Long March") to help introduce the Nu.Q(TM) platf...
2019-07-18 20:30
12315
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea
SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...
2019-07-17 21:00
2618
Kazia calls for greater awareness of the deadliest brain cancer in the US
SYDNEY, July 17, 2019 /PRNewswire/ -- This Glioblastoma Awareness Day, Australian oncology-focused biotech company, Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA), calls for greater awareness of the most lethal brain cancer in the US. Glioblastoma (GBM) is the most common, complex, treatment ...
2019-07-17 20:00
7795
AirXpanders® Announces Reduction in Force and Plan to Cease Operations
SAN JOSE, California, July 17, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the Company has reduced its workforce and plans to cease operations. ...
2019-07-17 07:17
12606
AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System
SAN JOSE, California, July 15, 2019 /PRNewswire/ -- AirXpanders, Inc. (ASX: AXP), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that the company has received U.S. Food and Drug Administration (FDA) 510(k...
2019-07-15 09:17
2134
Yuyu Pharma held the campaign for enhancing corporate transparency
SEOUL, South Korea, July 10, 2019 /PRNewswire/ -- Yuyu Pharma, a Korean
pharmaceutical company celebrated its third year of implementing Yuyu's
compliance management system by inviting senior management to its
"Self-Compliance Day" workshop.
2019-07-11 16:43
2363
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), aChina and U.S....
2019-07-11 04:01
2413
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding
AUSTIN, Texas, July 10, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded additional non-dilutive funding in the form of a non-repayable cash grant totaling approximately$1.4 million from the Walloon Region, Belgium. To date, Agen...
2019-07-10 20:30
13459
Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative
SMITHS FALLS, Ontario and TORONTO, July 10, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to announce a partnership with the Canadian Mental Health Association ("CMHA...
2019-07-10 20:00
8175
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST
SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed inChina with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of avapritini...
2019-07-10 10:23
7625
Medeon Led and Completed Investments in Panther Orthopedics and Prodeon
TAIPEI, , July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pioneerin...
2019-07-08 17:10
13675
iMedX, Inc. Launches Industry Leading Analytics and Business Intelligence with Acquisition of Prevalent, Inc. and Axcension, Inc.
Combined Technology & Teams Will Provide Healthcare Clients Unparalleled Insight into Operations and Billing Functions Existing iMedX Solutions Will Utilize Precision Analytics to Further Increase Efficiency and Boost Cash Flow ATLANTA and KATY, Texas, July 8, 2019 /PRNewswire/ -- iMedX, Inc. (i...
2019-07-08 13:03
2534
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 318 media titles]
2024-06-25 21:00
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15695
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13476
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
2024-06-19 11:38
9533
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9442
